
|Articles|August 25, 2022
Treating Patients with Gastric Cancer
This publication highlights a scientific interchange held to evaluate recent data on therapeutic options for advanced gastric and gastroesophageal cancers, explore evidence-based therapy approaches and sequencing strategies in patients with HER2+ disease, and discuss methods to optimize treatment selection and management.
Latest CME
Trending on OncLive
1
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
2
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma
5





































